Document is current
Any future updates will be listed below
-
Authors
Guilleminault, Laurent
Dupin, Clairelyne
Portel, Laurent
Zysman, Maeva
Flament, Thomas
Roux, Pauline
Costa, Nadège
Mounié, Michael
-
Funding
Funding for this research was provided by:
MSD
- License Information
-
More Information
Article History
Received: 9 August 2025
Accepted: 25 September 2025
First Online: 4 October 2025
Declarations
:
: LG has been an investigator in clinical trials for AstraZeneca, MSD, and Novartis; received grants or consultation fees from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi-Regeneron, Bayer, Chiesi, and MSD. CD has reported receiving personal fees or non-financial support from Astra Zeneca, Chiesi, GSK, Novartis, and Sanofi outside the submitted work. LP has received consulting fees from Astra Zeneca, Dom AIR, Sanofi-Regeneron, and SOS Oxygène not related to the work submitted. MZ has been an investigator in clinical trials for AstraZeneca, GSK, and Takeda; received grants or consultation fees from AstraZeneca, AVAD, GlaxoSmithKline, Novartis, and Sanofi-Regeneron, Chiesi, and Menarini not related to the work submitted. TF has reported receiving non-financial support from Astra Zeneca and Boehringer Ingelheim not related to the work submitted. PRC has reported receiving personal fees or non-financial support from Astra Zeneca, Chiesi, GSK, Novartis, and Sanofi outside the submitted work. The other co-authors declare no disclosure of interest.
